Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review

June 2021 | 57 pages | ID: K58520AB6EBEN
GlobalData

Abstracts

Karo Pharma AB (KARO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on development and commercialization of pharmaceutical products. It provides prescription medicines and over-the-counter products to pharmacies and directly to the healthcare sector across various countries with the Nordic region and Europe as its core markets. Under the Nytt project, Karo Pharma developed Baby Slide, a product that is developed to reduce stretch marks during childbirth. The company has brands spanning six key categories which include intimate care, dermatology, foot care, Wellness, Rx pharma care, and Pain, cough & cold. Karo Pharma AB is headquartered in, Stockholm, Sweden.

Karo Pharma AB Key Recent Developments

Apr 21,2021: Karo Pharma announces Interim report Q1 2021
Apr 21,2021: Karo Pharma 2021 Annual General Meeting
Mar 20,2021: Notice of Annual General Meeting of Karo Pharma Aktiebolag
Feb 18,2021: Year-end report 2020 Kv 4, October-December
Feb 03,2021: Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Karo Pharma AB - Key Facts
Karo Pharma AB - Key Employees
Karo Pharma AB - Key Employee Biographies
Karo Pharma AB - Major Products and Services
Karo Pharma AB - History
Karo Pharma AB - Company Statement
Karo Pharma AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Karo Pharma AB - Business Description
Business Segment: Hospital Supply
Overview
Performance
Business Segment: OTC (Over-the-counter Pharmaceuticals)
Overview
Performance
Business Segment: Rx (Prescription Pharmaceuticals)
Overview
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Finland
Performance
Geographical Segment: France
Performance
Geographical Segment: Norway
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Rest of world
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: The US
Performance
Karo Pharma AB - Corporate Strategy
Karo Pharma AB - SWOT Analysis
SWOT Analysis - Overview
Karo Pharma AB - Strengths
Karo Pharma AB - Weaknesses
Karo Pharma AB - Opportunities
Karo Pharma AB - Threats
Karo Pharma AB - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Karo Pharma AB, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 21, 2021: Karo Pharma announces Interim report Q1 2021
Apr 21, 2021: Karo Pharma 2021 Annual General Meeting
Mar 20, 2021: Notice of Annual General Meeting of Karo Pharma Aktiebolag
Feb 18, 2021: Year-end report 2020 Kv 4, October-December
Oct 30, 2020: Karo Pharma publishes third-quarter report 2020 and resolves on sale of own shares
Jul 21, 2020: Karo Pharma: Second-quarter report 2020
Apr 29, 2020: Karo : Interim report Q1 2020
Apr 29, 2020: Karo Pharma: Interim report Q1 2020
Feb 19, 2020: Karo Pharma: Year-end report 2019

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Karo Pharma AB, Key Facts
Karo Pharma AB, Key Employees
Karo Pharma AB, Key Employee Biographies
Karo Pharma AB, Major Products and Services
Karo Pharma AB, History
Karo Pharma AB, Subsidiaries
Karo Pharma AB, Key Competitors
Karo Pharma AB, Ratios based on current share price
Karo Pharma AB, Annual Ratios
Karo Pharma AB, Annual Ratios (Cont...1)
Karo Pharma AB, Annual Ratios (Cont...2)
Karo Pharma AB, Interim Ratios
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Karo Pharma AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Karo Pharma AB, Performance Chart (2016 - 2020)
Karo Pharma AB, Ratio Charts
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021